Literature DB >> 7162366

Rat lymphoma cell bioassay for prolactin: observations on its use and comparison with radioimmunoassay.

D M Lawson, N Sensui, D H Haisenleder, R R Gala.   

Abstract

The rat Nb2 node lymphoma cell bioassay (BA) for prolactin (PRL) was validated for use in our laboratories. During the course of this validation we observed that rat prolactin (NIAMDD-RP-1) stimulated cell division by as much as 16.5 fold over the range of 0.04 to 40.0 ng/ml at the end of 72 hours of incubation. We also observed a dose related increase in the size of the lymphoma cells. Prolactin concentrations in rat plasma, serum, anterior pituitary (AP) homogenates and milk were measured by both radioimmunoassay (RIA) and BA. In individual BA's there was parallelism between samples and standard; but when several dilutions of the same plasma and pituitary homogenates were assayed repeatedly, higher PRL levels were consistently observed for the more concentrated samples. At low or moderate levels of plasma PRL there was excellent agreement between RIA and BA; however, at high levels plasma PRL bioactivity exceeded radioimmunoactivity by a small, but significant, amount. A comparison of pituitary PRL concentrations measured by RIA and BA were in good agreement when homogenization was done at pH 10.6. However, when homogenization was done at pH 7.6, slightly but significantly more PRL was extracted when assayed by BA than when assayed by RIA.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7162366     DOI: 10.1016/0024-3205(82)90076-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

1.  Human follicular fluid: prolactin is biologically active and ovum fertilization correlates with estradiol concentration.

Authors:  M G Subramanian; A G Sacco; K S Moghissi; D M Magyar; M F Hayes; D M Lawson; R R Gala
Journal:  J In Vitro Fert Embryo Transf       Date:  1988-06

2.  Recombinant human prolactin promotes human beta cell survival via inhibition of extrinsic and intrinsic apoptosis pathways.

Authors:  L F Terra; M H Garay-Malpartida; R A M Wailemann; M C Sogayar; L Labriola
Journal:  Diabetologia       Date:  2011-03-11       Impact factor: 10.122

3.  Bioactive prolactin levels and risk of breast cancer: a nested case-control study.

Authors:  Shelley S Tworoger; Megan S Rice; Bernard A Rosner; Yvonne B Feeney; Charles V Clevenger; Susan E Hankinson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-10-14       Impact factor: 4.254

4.  Macroorchidism and testicular fibrosis associated with autoimmune thyroiditis.

Authors:  W H Hoffman; K T Kovacs; R R Gala; B A Keel; T S Jarrell; J O Ellegood; C L Burek
Journal:  J Endocrinol Invest       Date:  1991 Jul-Aug       Impact factor: 4.256

5.  Prolactin release by adipose explants, primary adipocytes, and LS14 adipocytes.

Authors:  Eric R Hugo; Dana C Borcherding; Keith S Gersin; Jean Loftus; Nira Ben-Jonathan
Journal:  J Clin Endocrinol Metab       Date:  2008-07-22       Impact factor: 5.958

6.  Circulating prolactin concentrations and risk of type 2 diabetes in US women.

Authors:  Jun Li; Megan S Rice; Tianyi Huang; Susan E Hankinson; Charles V Clevenger; Frank B Hu; Shelley S Tworoger
Journal:  Diabetologia       Date:  2018-10-11       Impact factor: 10.122

7.  The Eyes Have it! Protective Role of Prolactin in the Retina.

Authors:  David R Grattan
Journal:  EBioMedicine       Date:  2016-05-29       Impact factor: 8.143

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.